Expression of contactin 4 is associated with malignant behavior in pheochromocytomas and paragangliomas

Lucie Evenepoel, Francien H. Van Nederveen, Lindsey Oudijk, Thomas G. Papathomas, David F. Restuccia, Eric J.T. Belt, Wouter W. De Herder, Richard A. Feelders, Gaston J.H. Franssen, Marc Hamoir, Dominique Maiter, Hans K. Ghayee, Jerry W. Shay, Aurel Perren, Henri J.L.M. Timmers, Susanne Van Eeden, Laurent Vroonen, Selda Aydin, Mercedes Robledo, Miikka VikkulaRonald R. De Krijger, Winand N.M. Dinjens, Alexandre Persu, Esther Korpershoek

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Context: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine, usually benign, tumors. Currently, the only reliable criterion of malignancy is the presence of metastases. Objective: The aim of this study was to identify genes associated with malignancy in PPGLs. Design: Transcriptomic profiling was performed on 40 benign and 11 malignant PPGLs. Genes showing a significantly different expression between benign and malignant PPGLs with a ratio $4 were confirmed and tested in an independent series by quantitative real-time polymerase chain reaction (qRT-PCR). Immunohistochemistry was performed for the validated genes on 109 benign and 32 malignant PPGLs. Functional assays were performed with hPheo1 cells. Setting: This study was conducted at the Department of Pathology of the Erasmus MC University Medical Center Rotterdam Human Molecular Genetics laboratory of the de Duve Institute, University of Louvain. Patients: PPGL samples from 179 patients, diagnosed between 1972 and 2015, were included. Main outcome measures: Associations between gene expression and malignancy were tested using supervised clustering approaches. Results: Ten differentially expressed genes were selected based on messenger RNA (mRNA) expression array data. Contactin 4 (CNTN4) was overexpressed in malignant vs benign tumors [4.62-fold; false discovery rate (FDR), 0.001]. Overexpression at the mRNA level was confirmed using qRTPCR (2.90-fold, P=0.02; validation set: 4.26-fold, P=0.005). Consistent findings were obtained in The Cancer Genome Atlas cohort (2.7-fold; FDR, 0.02). CNTN4 protein was more frequently expressed in malignant than in benign PPGLs by immunohistochemistry (58% vs 17%; P=0.002). Survival after 7 days of culture under starvation conditions was significantly enhanced in hPheo1 cells transfected with CNTN4 complementary DNA. Conclusion: CNTN4 expression is consistently associated with malignant behavior in PPGLs.

Original languageEnglish (US)
Pages (from-to)46-55
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume103
Issue number1
DOIs
StatePublished - 2018

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Expression of contactin 4 is associated with malignant behavior in pheochromocytomas and paragangliomas'. Together they form a unique fingerprint.

Cite this